{"id":137254,"date":"2026-07-01T15:31:44","date_gmt":"2026-07-01T10:01:44","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=137254"},"modified":"2026-07-01T15:31:46","modified_gmt":"2026-07-01T10:01:46","slug":"balaxi-pharmaceuticals-ltd-q1-results-fy27","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/balaxi-pharmaceuticals-ltd-q1-results-fy27\/","title":{"rendered":"Balaxi Pharmaceuticals Ltd Q1 Results FY27: Date, Revenue Estimates and What to Expect"},"content":{"rendered":"
<\/div>\n

Balaxi Pharmaceuticals Ltd Q1 Results FY27 expected July-August 2026. CMP Rs.24 on NSE. Revenue estimate Rs.71-82 Cr. Analyst target Rs.23-27.<\/em><\/p>\n

Balaxi Pharmaceuticals Ltd<\/a> is expected to announce its Q1 FY27 (April to June 2026) financial results in July or August 2026. As of July 2026, the stock trades around Rs.24 on NSE with a market capitalisation of approximately Rs.132 Cr and a trailing P\/E of 92.0x. This article covers Balaxi Pharmaceuticals Ltd’s Q1 FY27 revenue and PAT estimates, Q4 FY26 actual performance for context, key catalysts and risks, technical levels, and the 12-month share price target.<\/p>\n

India’s pharmaceutical sector is seeing sustained domestic formulation growth and recovering export revenues heading into Q1 FY27. The Balaxi Pharmaceuticals Ltd Q1 Results FY27 Q1 prediction is shaped by these sector Q1 expectations.<\/p>\n

This Balaxi Pharmaceuticals Ltd Q1 Results FY27 Q1 result preview covers Q1 expectations across estimates, catalysts, risks, technicals and the 12-month price target. Specifically, this article covers Balaxi Pharmaceuticals Ltd\\’s Q1 FY27 analyst estimates, Q4 FY26 actual performance for context, key catalysts and risks to watch, technical levels, and the 12-month analyst share price target.<\/p>\n

Get Free Investment Predictions and Balaxi Pharmaceuticals Ltd Research at Univest<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n